drugset / Trial / NCT05844527
Safety and Efficacy of MRG-001 in Wound Healing in Abdominoplasty Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Surgical excisions are one of the most frequent cutaneous wounds. This study will compare the safety and preliminary efficacy of a novel fixed-dose combination drug MRG-001 in pre-abdominoplasty surgical excisions and scar appearance in subjects undergoing elective abdominoplasty.
Timeline
- Start
- 2023-11-20
- Primary completion
- 2024-09-01
- Completion
- 2024-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MRG-001 | Unknown | 0.01 ml | Subcutaneous |
Indications
No indication recorded.